Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

Biotechnology

Healthcare
$8.44 +3.04%

+$0.26 today

Market cap
$547.12M
Beta
1.80
P/E (TTM)
-1.7
EPS (TTM)
-$5.11
52W Low $5.37High $17.58

Volume 2.36M

Average 1.24M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.12B

FY 2025 · Annual

-18.7% YoY

Liabilities

$611.11M

FY 2025 · Annual

-7.6% YoY

Equity

$508.59M

FY 2025 · Annual

-29.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.55B1.32B944.07M561.57M167.2M
Short-term Investments0000255.42M
Net Receivables149.9M84.03M17.9M22.44M24.03M
Inventory3.36M4.36M46K00
Other Current Assets698K8.71M18.99M18.73M25.19M
Total Current Assets1.72B1.45B1B602.74M471.84M
Property, Plant & Equipment (Net)145.77M718.79M394.99M598.16M528.7M
Goodwill21.31M60.21M49.24M00
Intangible Assets21.64M111.04M82.74M72.51M56.92M
Long-term Investments115.23M111.79M77.91M48.7M15.07M
Tax Assets00000
Other Non-current Assets43.99M87.41M58.71M55.34M47.17M
Total Non-current Assets347.95M1.09B663.59M774.71M647.86M
Total Assets2.07B2.54B1.67B1.38B1.12B
Account Payables8.19M10.45M9.32M14.17M10.57M
Short-term Debt00000
Tax Payables00000
Deferred Revenue33.24M47.82M48.5M30.6M19.98M
Other Current Liabilities40.31M52.51M54.38M26.62M32.12M
Total Current Liabilities134.76M172.96M163.86M107.27M95.97M
Long-term Debt0000417.08M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)155.99M174.77M158.06M98.78M0
Other Non-current Liabilities190.58M42.06M24.43M16.58M98.06M
Total Non-current Liabilities368.85M630.08M404.33M554.13M515.14M
Total Liabilities503.61M803.04M568.19M661.39M611.11M
Common Stock161K190K5K5K6K
Retained Earnings(2.3B)(4.4B)(5.29B)(5.84B)(6.15B)
Accumulated OCI(1.72M)(2.63M)1.48M(1.81M)1.85M
Other Stockholders Equity00000
Minority Interest62.01M0000
Total Equity1.57B1.74B1.1B716.06M508.59M
Total Debt23.03M442.59M239.31M467.73M439.89M
Net Debt(1.53B)(873.2M)(704.76M)(93.84M)272.68M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$143.9M
Short-term Investments$229.6M
Receivables$19.8M
Other Current$16.7M
Total Current Assets$410.0M
PP&E (Net)$516.8M
Intangible Assets$48.9M
Long-term Investments$14.7M
Other Non-current$42.7M
Total Non-current Assets$623.1M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is PP&E (Net) at $516.8M, about 50.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportOct 29, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026

How much cash does DNA have?

Ginkgo Bioworks Holdings, Inc. (DNA) reported $167.20M in cash and equivalents in fiscal 2025.

How much debt does DNA carry?

Ginkgo Bioworks Holdings, Inc. (DNA) reported $439.88M of total debt, with net debt of $272.68M.